|1.||Chen, Yeh-Long: 11 articles (01/2015 - 02/2005)|
|2.||Tzeng, Cherng-Chyi: 10 articles (01/2015 - 02/2005)|
|3.||Tseng, Chih-Hua: 8 articles (01/2015 - 03/2008)|
|4.||Zenser, Terry V: 5 articles (06/2013 - 08/2002)|
|5.||Yang, Chia-Ning: 5 articles (04/2013 - 03/2008)|
|6.||Lu, Pei-Jung: 5 articles (04/2013 - 03/2008)|
|7.||Lakshmi, Vijaya M: 4 articles (03/2009 - 08/2002)|
|8.||Dashwood, R H: 4 articles (08/2003 - 02/2001)|
|9.||Xu, M: 4 articles (08/2003 - 02/2001)|
|10.||Chiu, Chien-Chih: 3 articles (11/2015 - 01/2015)|
09/01/2012 - "Despite the emergence of CQ resistance, synthetic quinoline derivatives remain validated leads for new drug discovery, especially if they are effective against CQ-resistant strains of malaria. "
01/01/2008 - "Here we summarize the main elements of quinoline resistance and reversion of quinoline resistance related to malaria."
08/24/2006 - "Remarkably, antiprion SAR in ScN2a cells were similar to antimalarial SAR in a cell model of malaria, particularly for the sulfonamide quinoline derivatives, suggesting that some molecular targets of antiprion and antimalarial substances overlap."
08/01/2006 - "Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum."
01/01/2004 - "To date, malaria control has relied heavily on a comparatively small number of chemically related drugs, belonging to either the quinoline or the antifolate groups. "
08/01/2015 - "In the present study, a novel quinolone-indolone conjugate, QIC1 [9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl -1-piperazinyl) -6-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl) -7-oxo-2H-(1,4) oxazino(2,3,4-ij)quinoline], which targeted EGFR, was synthesized in order to investigate the anticancer activity and the potential mechanisms underlying the effect of this compound in human cancer cells. "
02/01/2015 - "The tricyclic quinoline compound CX-4945 (R2 = COOH) is the first bioavailable CK2 inhibitor used in human clinical trials for advanced solid tumors. "
04/01/2013 - "In the present study, we report the synthesis, biologic evaluation, and molecular mechanism of a series of substituted indeno[1,2-c]quinoline derivatives against the growth of several human cancer cell lines. "
05/27/2011 - "The present study was undertaken to explore delivery to the cancer sites by way of phosphate or quinoline modifications. "
08/01/2000 - "Our study on the cytotoxicity of imidazoquinolinedione derivatives has revealed that 7,8-dihydro-10H-[1,4]oxazino-[3',4':2,3]imidazo[4,5-g]quinoline-5, 12-dione (19), a tetracyclic heteroquinone analogue, exhibited high cytotoxicity on human colon tumor cell (HCT 15) in vitro SRB assay. "
|3.||Hepatocellular Carcinoma (Hepatoma)
01/01/2000 - "The heterocyclic aromatic amine (HAA) 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ) induces intestinal tumours and hepatocellular carcinomas in rats, but no tumourigenic effects have been identified in the kidney. "
05/01/1994 - "p53 gene mutation in hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates."
02/01/1994 - "Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline."
11/01/1992 - "2-Amino-3-methylimidazo[4.5-f]quinoline (IQ) is a potent bacterial mutagen and rodent carcinogen which also produces hepatocellular carcinoma in monkeys. "
10/15/1985 - "Activated c-raf gene in a rat hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline."
|4.||Breast Neoplasms (Breast Cancer)
09/01/2011 - "Scrape load/dye transfer studies showed that 100 nM of PQ15, a third generation substituted quinoline, causes a 4.5-fold increase of gap junction activity in T47D breast cancer cells. "
09/01/2015 - "Anti-breast cancer activity of some novel quinoline derivatives."
03/15/2014 - "The substituted quinoline, 6-methoxy-8-[(3-aminopropyl)amino]-4-methyl-5-(3-trifluoromethyl-phenyloxy)quinolone (PQ1), has been shown to restore GJIC and increase connexin expression in breast cancer cell lines while not affecting normal mammary cells, suggesting that it may provide effective anticancer treatment with less detrimental effects. "
08/01/2012 - "New quinoline derivatives 6, 7 and 19, pyrimidoquinoline derivatives 8-16 and triazolopyrimidoquinoline derivatives 17 and 18 bearing a bromo-substituent were synthesized starting from 3-(4-Bromophenylamino)-5,5-dimethylcyclohex-2-enone 3. All the newly synthesized compounds were evaluated for their in vitro anticancer activity against human breast cancer cell line (MCF7). "
11/01/2004 - "We showed that five antiproliferative quinoline compounds in the National Cancer Institute database stimulated cell differentiation at growth inhibitory concentrations (3-14 microM) in MCF-7 human breast tumor cells in vitro. "
06/01/1963 - "Efficacy of a 2-phenyl quinoline against experimental Schistosoma mansoni infections in mice and monkeys."
09/01/1995 - "The third significant contribution is the molecular studies on the mechanisms of drug resistance Plasmodium falciparum of both the antifolate- and quinoline-containing drugs and the identification and subsequent biochemical and molecular analysis of drug resistance in Giardia intestinalis infections."
08/01/1986 - "[Diagnosis of neonatal chlamydial infection by fluorescent antibody technique and its treatment with a new quinoline derivative]."
10/01/1975 - "An hypothesis is presented to explain the red cell lysis which accompanies an acute malarial infection, as well as the mode of action of certain schizonticidal drugs in the quinoline and acridine series. "
03/24/1952 - "[Haemoproteus columbae infection of pigeons in Tunisia treated with diethylamino-4' methyl-1 butylamino-4 chloro-7 quinoline]."
|8.||dofequidar (MS 209)
|10.||Succinic Acid (Succinate)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)
|5.||Renal Dialysis (Hemodialysis)